IPO Sage Therapeutics (SAGE) is a biopharmaceutical company that develops and commercializes novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders, where there are inadequate or no approved existing therapies.
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
No comments:
Post a Comment